Total Payments
$105,841
2024 Payments
$141.98
Companies
26
Transactions
329
Medicare Patients
744
Medicare Billing
$94,422
Payment Breakdown by Category
Other$53,332 (50.4%)
Travel$20,052 (18.9%)
Consulting$18,826 (17.8%)
Food & Beverage$5,858 (5.5%)
Research$5,065 (4.8%)
Education$2,708 (2.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $44,361 | 27 | 41.9% |
| Travel and Lodging | $20,052 | 31 | 18.9% |
| Consulting Fee | $18,826 | 7 | 17.8% |
| Honoraria | $8,971 | 4 | 8.5% |
| Food and Beverage | $5,858 | 189 | 5.5% |
| Unspecified | $5,065 | 3 | 4.8% |
| Education | $2,708 | 68 | 2.6% |
Payments by Type
General
$100,776
326 transactions
Research
$5,065
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $35,850 | 123 | $0 (2022) |
| GENZYME CORPORATION | $34,277 | 40 | $0 (2024) |
| F. Hoffmann-La Roche AG | $14,225 | 4 | $0 (2018) |
| PFIZER INC. | $11,396 | 14 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $7,340 | 16 | $0 (2018) |
| Amgen Inc. | $431.68 | 19 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $353.54 | 21 | $0 (2018) |
| Janssen Biotech, Inc. | $322.35 | 10 | $0 (2018) |
| Incyte Corporation | $222.62 | 8 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $201.50 | 12 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $141.98 | 2 | Astellas Pharma US Inc ($99.00) |
| 2023 | $6,192 | 6 | GENZYME CORPORATION ($6,192) |
| 2022 | $10,870 | 10 | GENZYME CORPORATION ($10,520) |
| 2021 | $8,648 | 6 | GENZYME CORPORATION ($8,648) |
| 2020 | $4,355 | 5 | Alexion Pharmaceuticals, Inc. ($2,400) |
| 2019 | $20,421 | 29 | Alexion Pharmaceuticals, Inc. ($13,466) |
| 2018 | $29,045 | 90 | F. Hoffmann-La Roche AG ($14,225) |
| 2017 | $26,168 | 181 | Alexion Pharmaceuticals, Inc. ($13,472) |
All Payment Transactions
329 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/10/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.00 | General |
| 07/18/2024 | GENZYME CORPORATION | ENJAYMO (Biological) | Food and Beverage | In-kind items and services | $42.98 | General |
| Category: Hematology | ||||||
| 10/03/2023 | GENZYME CORPORATION | CABLIVI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,708.00 | General |
| Category: Hematology | ||||||
| 09/20/2023 | GENZYME CORPORATION | ENJAYMO (Biological), CABLIVI | Food and Beverage | In-kind items and services | $56.83 | General |
| Category: Hematology | ||||||
| 05/31/2023 | GENZYME CORPORATION | CABLIVI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,660.00 | General |
| Category: Hematology | ||||||
| 05/31/2023 | GENZYME CORPORATION | CABLIVI (Biological) | Travel and Lodging | In-kind items and services | $672.42 | General |
| Category: Hematology | ||||||
| 05/31/2023 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $38.37 | General |
| Category: Hematology | ||||||
| 04/26/2023 | GENZYME CORPORATION | CABLIVI (Biological), ENJAYMO | Food and Beverage | In-kind items and services | $56.50 | General |
| Category: Hematology | ||||||
| 11/10/2022 | GENZYME CORPORATION | CABLIVI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,394.00 | General |
| Category: Hematology | ||||||
| 11/10/2022 | GENZYME CORPORATION | CABLIVI (Biological) | Travel and Lodging | In-kind items and services | $982.00 | General |
| Category: Hematology | ||||||
| 11/10/2022 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $114.30 | General |
| Category: Hematology | ||||||
| 05/18/2022 | Takeda Pharmaceuticals U.S.A., Inc. | — | Education | In-kind items and services | $99.99 | General |
| 04/14/2022 | GENZYME CORPORATION | CABLIVI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,788.00 | General |
| Category: Hematology | ||||||
| 04/14/2022 | GENZYME CORPORATION | CABLIVI (Biological) | Travel and Lodging | In-kind items and services | $1,182.97 | General |
| Category: Hematology | ||||||
| 04/14/2022 | GENZYME CORPORATION | CABLIVI (Biological) | Travel and Lodging | In-kind items and services | $483.00 | General |
| Category: Hematology | ||||||
| 04/14/2022 | GENZYME CORPORATION | CABLIVI (Biological) | Travel and Lodging | In-kind items and services | $451.09 | General |
| Category: Hematology | ||||||
| 04/14/2022 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Hematology | ||||||
| 02/15/2022 | Alexion Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $250.00 | General |
| 09/09/2021 | GENZYME CORPORATION | CABLIVI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,906.00 | General |
| Category: Hematology | ||||||
| 09/09/2021 | GENZYME CORPORATION | CABLIVI (Biological) | Travel and Lodging | In-kind items and services | $710.91 | General |
| Category: Hematology | ||||||
| 09/09/2021 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Hematology | ||||||
| 06/03/2021 | GENZYME CORPORATION | CABLIVI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,519.00 | General |
| Category: Hematology | ||||||
| 05/06/2021 | GENZYME CORPORATION | CABLIVI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,519.00 | General |
| Category: Hematology | ||||||
| 01/23/2021 | GENZYME CORPORATION | CABLIVI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $868.00 | General |
| Category: Hematology | ||||||
| 11/18/2020 | Alexion Pharmaceuticals, Inc. | Ultomiris (Drug) | Consulting Fee | Cash or cash equivalent | $2,250.00 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Atypcial Hemolytic-Uremic Syndrome aHUS Registry | Alexion Pharmaceuticals, Inc. | $5,065 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 118 | 181 | $75,015 | $18,075 |
| 2022 | 6 | 168 | 237 | $82,171 | $20,930 |
| 2021 | 6 | 235 | 325 | $108,826 | $28,557 |
| 2020 | 7 | 223 | 318 | $94,222 | $26,861 |
Total Patients
744
Total Services
1,061
Medicare Billing
$94,422
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 91 | 154 | $57,504 | $13,789 | 24.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 27 | 27 | $17,511 | $4,285 | 24.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 72 | 105 | $38,518 | $9,161 | 23.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 24 | 25 | $14,320 | $3,884 | 27.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 22 | 37 | $10,896 | $2,980 | 27.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 23 | 39 | $8,042 | $2,182 | 27.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 13 | 13 | $8,389 | $2,173 | 25.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 14 | 18 | $2,006 | $549.36 | 27.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 76 | 116 | $42,920 | $10,057 | 23.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 41 | 41 | $23,042 | $6,516 | 28.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 41 | 64 | $18,432 | $5,246 | 28.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 52 | 74 | $14,874 | $4,164 | 28.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 12 | 12 | $7,596 | $2,025 | 26.7% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 13 | 18 | $1,962 | $549.00 | 28.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 68 | 95 | $27,930 | $7,483 | 26.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 44 | 81 | $23,166 | $6,847 | 29.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 34 | 34 | $18,904 | $5,573 | 29.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 34 | 60 | $12,000 | $3,461 | 28.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 11 | 11 | $6,193 | $1,801 | 29.1% |
| 99449 | Telephone or internet assessment and management service provided by consultative physician, 31 minutes or more of medical consultative discussion and review | Facility | 2020 | 19 | 19 | $4,085 | $1,120 | 27.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 13 | 18 | $1,944 | $575.64 | 29.6% |
About Dr. Robert Kaplan, MD
Dr. Robert Kaplan, MD is a Hematology healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1922004027.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Kaplan, MD has received a total of $105,841 in payments from pharmaceutical and medical device companies, with $141.98 received in 2024. These payments were reported across 329 transactions from 26 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($44,361).
As a Medicare-enrolled provider, Kaplan has provided services to 744 Medicare beneficiaries, totaling 1,061 services with total Medicare billing of $94,422. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology
- Location Pittsburgh, PA
- Active Since 06/23/2005
- Last Updated 10/01/2020
- Taxonomy Code 207RH0000X
- Entity Type Individual
- NPI Number 1922004027
Products in Payments
- SOLIRIS (Drug) $28,416
- CABLIVI (Biological) $27,259
- ELIQUIS (Drug) $18,555
- Non-Covered Product (Drug) $14,225
- CABLIVI (Drug) $6,809
- Ultomiris (Drug) $2,400
- IMBRUVICA (Drug) $322.35
- JADENU (Drug) $282.68
- Blincyto (Biological) $186.70
- ELITEK (Drug) $175.00
- Soliris (Drug) $150.00
- Kyprolis (Biological) $132.04
- EMPLICITI (Biological) $130.57
- Imbruvica (Drug) $128.17
- JAKAFI (Drug) $123.62
- EMEND (Drug) $105.21
- ENJAYMO (Biological) $99.81
- Folotyn (Drug) $91.55
- VELCADE (Drug) $75.24
- Neulasta (Biological) $74.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology Doctors in Pittsburgh
Craig Seaman, M.d, M.D
Hematology — Payments: $83,730
Hematology $83,730
John Byrd, M.d, M.D
Hematology — Payments: $53,819
Hematology $53,819
Dr. Laura Decastro, M.d, M.D
Hematology — Payments: $23,132
Hematology $23,132
Santhosh Sadashiv, Md, MD
Hematology — Payments: $21,349
Hematology $21,349
Ranjita Pallavi, M.d, M.D
Hematology — Payments: $4,797
Hematology $4,797
Dr. Olukemi Esan, M.b.,B.s, M.B.,B.S
Hematology — Payments: $102.84
Hematology $102.84